Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
August 8, 2014
Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer
Yingqiu Xie, Wenfu Lu, Shenji Liu, et al.
Molecular Oncology
|
June 10, 2014
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis
Yingqiu Xie, Shenji Liu, Wenfu Lu, et al.
Molecular Imaging and Biology
|
August 20, 2017
Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model
Mohammed N Tantawy, H Charles Manning, Todd E Peterson, et al.
Oncogene
|
December 21, 2018
Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer
Yingqiu Xie, Haiyan Fan, Wenfu Lu, et al.
Oncotarget
|
January 19, 2015
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination
Wenfu Lu, Shenji Liu, Bo Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 2, 2025
C1q<sup>+</sup> Macrophage-Tumor Cell Interaction Promoted Tumorigenesis via GPR17/PI3K/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma
Yunzhi Liu, Cuicui Huang, Min Luo, et al.
Molecular Cancer Therapeutics
|
November 9, 2014
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling
Jackie Wanjala, Barry S Taylor, Caren Chapinski, et al.
Science Signaling
|
December 17, 2024
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2
Sherly I Celada, Guoliang Li, Lindsay J Celada, et al.
Cancer Research
|
September 2, 2020
KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
Guoliang Li, Thanigaivelan Kanagasabai, Wenfu Lu, et al.
Molecular Oncology
|
July 26, 2023
Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
Sherly I Celada, Guoliang Li, Lindsay J Celada, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Molecular Endocrinology (Baltimore, Md.)
|
August 8, 2014
Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer
Yingqiu Xie, Wenfu Lu, Shenji Liu, et al.
Molecular Oncology
|
June 10, 2014
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis
Yingqiu Xie, Shenji Liu, Wenfu Lu, et al.
Molecular Imaging and Biology
|
August 20, 2017
Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model
Mohammed N Tantawy, H Charles Manning, Todd E Peterson, et al.
Oncogene
|
December 21, 2018
Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer
Yingqiu Xie, Haiyan Fan, Wenfu Lu, et al.
Oncotarget
|
January 19, 2015
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination
Wenfu Lu, Shenji Liu, Bo Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 2, 2025
C1q<sup>+</sup> Macrophage-Tumor Cell Interaction Promoted Tumorigenesis via GPR17/PI3K/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma
Yunzhi Liu, Cuicui Huang, Min Luo, et al.
Molecular Cancer Therapeutics
|
November 9, 2014
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling
Jackie Wanjala, Barry S Taylor, Caren Chapinski, et al.
Science Signaling
|
December 17, 2024
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2
Sherly I Celada, Guoliang Li, Lindsay J Celada, et al.
Cancer Research
|
September 2, 2020
KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
Guoliang Li, Thanigaivelan Kanagasabai, Wenfu Lu, et al.
Molecular Oncology
|
July 26, 2023
Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
Sherly I Celada, Guoliang Li, Lindsay J Celada, et al.
Page
of 4